Kristin Klemmetsby Solli

8PUBLICATIONS
23CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Clinical psychologyPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 28, 2026
Genetic Influence on Extended-Release Naltrexone Treatment Outcomes in Patients with Opioid Use Disorder: An Exploratory Study.

Farid Juya, Kristin Klemmetsby Solli, Ann-Christin Sannes

|Dec 24, 2025
Chronic Pain and Posttraumatic Stress Among Patients in Substance Use Treatment: Protocol for NOR-APT, a Longitudinal Cohort Study.

Ingeborg Skjærvø, Anne Marciuch, Linn Wergeland Digranes

|Oct 21, 2025
Impact of dextroamphetamine substitution on the use of illicit amphetamines in adults with amphetamine dependence: a study protocol for the multicentre double blind randomised controlled trial ATLAS4Dependence.

Fatemeh Chalabianloo, Lars T Fadnes, Jon Mordal

|Apr 29, 2025
Pain intensity in patients using extended-release naltrexone or opioid agonists and its effect on extended-release naltrexone treatment outcomes.

Farid Juya, Kristin K Solli, Line Holtan

|Feb 26, 2025
Pain Intensity in Patients with Opioid Use Disorder on Extended-Release Naltrexone or Opioid Agonists; The Role of COMT rs4680 and OPRM1 rs1799971: An Exploratory Study.

Farid Juya, Ann Christin Sannes, Kristin Klemmetsby Solli

|Sep 23, 2022
Impact of Impulsivity, Hyperactivity, and Inattention on Discontinuation Rate among Opioid-Dependent Patients Treated with Extended-Release Naltrexone.

Ann Tarja Karlsson, John-Kåre Vederhus, Thomas Clausen

Pageof 2

Frequent Collaborators

3 joint publications

Farid Juya

3 joint publications

Jon Mordal

3 joint publications

Lars Tanum

3 joint publications

Bente Weimand